SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001718111-19-000002
Filing Date
2019-01-29
Accepted
2019-01-29 10:21:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 13DA.htm SC 13D/A 60356
  Complete submission text file 0001718111-19-000002.txt   62037
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Subject) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88741 | Film No.: 19547434
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 950 THIRD AVENUE 25TH FL NEW YORK NY 10022
Business Address 950 THIRD AVENUE 25TH FL NEW YORK NY 10022 212-878-3702
Puissance Cross-Border Opportunities III LLC (Filed by) CIK: 0001718111 (see all company filings)

IRS No.: 611853871 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 6799 Investors, NEC
Assistant Director 8